Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. IBM
9. HOOD
10. DFTX

Go back to Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026
(NASDAQ: MIRM) Delayed: 107.77 --0 (-0%)
Previous Close $107.77    52 Week High $ 
Open $107.77    52 Week Low $ 
Day High $107.77    P/E N/A 
Day Low $107.77    EPS $ 
Volume 449